Supernus Pharmaceuticals plans to acquire assets related to a compound known as NV-5138 from Navitor Pharmaceuticals for up to $350 million.

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro, Senior Technology Scientist at AstraZeneca, about his research, as well as the role of compound ...

Researchers in Purdue University’s College of Pharmacy are leveraging the dual roles played by an enzyme found in both cancer cells and T cells to create a novel cancer immunotherapy compound.

MONTGOMERY, Ala.--(BUSINESS WIRE)--Kowa Pharmaceuticals America, Inc., a U.S. subsidiary of Kowa Company Ltd., a privately held, multinational company based in Japan, today announced that it has ...

Scientists at City University of Hong Kong (CityUHK) have made progress in recent months with the discovery of a novel ...

--Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination --Preclinical data demonstrates the effectiveness of ...

HONG KONG (Reuters) - Scientists in Hong Kong and the United States have identified a synthetic compound which appears to be able to stop the replication of influenza viruses, including the H5N1 bird ...

BALTIMORE--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced ...

Researchers are leveraging the dual roles played by an enzyme found in both cancer cells and T cells to create a novel cancer immunotherapy compound. Researchers in Purdue University's College of ...

MARLBOROUGH, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make ...